Coordinated regulation of IGF1R by HIF1α and HIF2α enhances chemoresistance in glioblastoma

BackgroundThis study investigates whether Hypoxia-Inducible Factor 1 alpha (HIF1α) and Hypoxia-Inducible Factor 2 alpha (HIF2α) coordinately regulate insulin-like growth factor 1 receptor (IGF1R) expression, thereby influencing chemosensitivity in glioblastoma multiforme (GBM).MethodsWe analyzed the...

Full description

Saved in:
Bibliographic Details
Main Authors: Bin Liao, Pan Wang, Sheng Gong, Lu Zhao, Jie Liu, Nan Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1575332/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850185629494673408
author Bin Liao
Bin Liao
Pan Wang
Sheng Gong
Lu Zhao
Lu Zhao
Jie Liu
Jie Liu
Nan Wu
Nan Wu
author_facet Bin Liao
Bin Liao
Pan Wang
Sheng Gong
Lu Zhao
Lu Zhao
Jie Liu
Jie Liu
Nan Wu
Nan Wu
author_sort Bin Liao
collection DOAJ
description BackgroundThis study investigates whether Hypoxia-Inducible Factor 1 alpha (HIF1α) and Hypoxia-Inducible Factor 2 alpha (HIF2α) coordinately regulate insulin-like growth factor 1 receptor (IGF1R) expression, thereby influencing chemosensitivity in glioblastoma multiforme (GBM).MethodsWe analyzed the expression and correlation of HIF1α, HIF2α, and IGF1R in glioma using The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CGGA) databases. Immunohistochemistry (IHC) was performed to detect the expression of HIF1α, HIF2α, and IGF1R in GBM tissues and cells, as well as oxygen tension. Cell cycle analysis, apoptosis assays, lactate dehydrogenase (LDH) release measurements, Western blotting, and xenograft tumor models were employed to explore the synergistic regulation of IGF1R by HIF1α and HIF2α, focusing on activation of the PI3K/AKT signaling pathway and its contribution to GBM drug resistance. Chromatin immunoprecipitation-quantitative PCR (ChIP-qPCR) and dual-luciferase reporter assays were used to investigate the binding sites of HIF1α and HIF2α involved in regulating IGF1R.ResultsOur study demonstrated that HIF1α and HIF2α were highly expressed in GBM tissues and hypoxia-cultured cells, and their expression positively correlated with IGF1R expression. Simultaneous knockout of HIF1α and HIF2α in GBM cells resulted in the highest LDH release and apoptosis rates under hypoxic conditions, accompanied by the most significant decrease in IGF1R, p-PDK1, and p-AKT levels. Knockout of IGF1R in tumor cells under hypoxia led to an increas of LDH release and apoptosis rates, and reduced phosphorylation of PDK1 and AKT. In addition, we demonstrated that HIF1α and HIF2α promoted IGF1R expression by binding to a specific hypoxia response element (HRE) sequence (5′-GAACGTGCCT-3′) within the IGF1R promoter using dual-luciferase reporter system.ConclusionGlioblastoma cells, residing within a hypoxic microenvironment, exhibit high expression of HIF1α and HIF2α. These transcription factors promote the upregulation of IGF1R, which subsequently activates the PI3K/AKT signaling pathway. This activation, in turn, promotes cell proliferation and chemoresistance, ultimately contributing to tumor malignancy.
format Article
id doaj-art-5cafeff0dae2417693aa3b8741da41dd
institution OA Journals
issn 1663-9812
language English
publishDate 2025-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-5cafeff0dae2417693aa3b8741da41dd2025-08-20T02:16:39ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-04-011610.3389/fphar.2025.15753321575332Coordinated regulation of IGF1R by HIF1α and HIF2α enhances chemoresistance in glioblastomaBin Liao0Bin Liao1Pan Wang2Sheng Gong3Lu Zhao4Lu Zhao5Jie Liu6Jie Liu7Nan Wu8Nan Wu9Chongqing Medical University, Chongqing, ChinaDepartment of Neurosurgery, Chongqing Research Center for Glioma Precision Medicine, Chongqing General Hospital, Chongqing University, Chongqing, ChinaDepartment of Neurosurgery, Chongqing Research Center for Glioma Precision Medicine, Chongqing General Hospital, Chongqing University, Chongqing, ChinaDepartment of Neurosurgery, Chongqing Research Center for Glioma Precision Medicine, Chongqing General Hospital, Chongqing University, Chongqing, ChinaChongqing Medical University, Chongqing, ChinaDepartment of Neurosurgery, Chongqing Research Center for Glioma Precision Medicine, Chongqing General Hospital, Chongqing University, Chongqing, ChinaChongqing Medical University, Chongqing, ChinaDepartment of Neurosurgery, Chongqing Research Center for Glioma Precision Medicine, Chongqing General Hospital, Chongqing University, Chongqing, ChinaChongqing Medical University, Chongqing, ChinaDepartment of Neurosurgery, Chongqing Research Center for Glioma Precision Medicine, Chongqing General Hospital, Chongqing University, Chongqing, ChinaBackgroundThis study investigates whether Hypoxia-Inducible Factor 1 alpha (HIF1α) and Hypoxia-Inducible Factor 2 alpha (HIF2α) coordinately regulate insulin-like growth factor 1 receptor (IGF1R) expression, thereby influencing chemosensitivity in glioblastoma multiforme (GBM).MethodsWe analyzed the expression and correlation of HIF1α, HIF2α, and IGF1R in glioma using The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CGGA) databases. Immunohistochemistry (IHC) was performed to detect the expression of HIF1α, HIF2α, and IGF1R in GBM tissues and cells, as well as oxygen tension. Cell cycle analysis, apoptosis assays, lactate dehydrogenase (LDH) release measurements, Western blotting, and xenograft tumor models were employed to explore the synergistic regulation of IGF1R by HIF1α and HIF2α, focusing on activation of the PI3K/AKT signaling pathway and its contribution to GBM drug resistance. Chromatin immunoprecipitation-quantitative PCR (ChIP-qPCR) and dual-luciferase reporter assays were used to investigate the binding sites of HIF1α and HIF2α involved in regulating IGF1R.ResultsOur study demonstrated that HIF1α and HIF2α were highly expressed in GBM tissues and hypoxia-cultured cells, and their expression positively correlated with IGF1R expression. Simultaneous knockout of HIF1α and HIF2α in GBM cells resulted in the highest LDH release and apoptosis rates under hypoxic conditions, accompanied by the most significant decrease in IGF1R, p-PDK1, and p-AKT levels. Knockout of IGF1R in tumor cells under hypoxia led to an increas of LDH release and apoptosis rates, and reduced phosphorylation of PDK1 and AKT. In addition, we demonstrated that HIF1α and HIF2α promoted IGF1R expression by binding to a specific hypoxia response element (HRE) sequence (5′-GAACGTGCCT-3′) within the IGF1R promoter using dual-luciferase reporter system.ConclusionGlioblastoma cells, residing within a hypoxic microenvironment, exhibit high expression of HIF1α and HIF2α. These transcription factors promote the upregulation of IGF1R, which subsequently activates the PI3K/AKT signaling pathway. This activation, in turn, promotes cell proliferation and chemoresistance, ultimately contributing to tumor malignancy.https://www.frontiersin.org/articles/10.3389/fphar.2025.1575332/fullglioblastoma multiformeHIF1αHIF2αIGF1Rhypoxic microenvironmentchemoresistance
spellingShingle Bin Liao
Bin Liao
Pan Wang
Sheng Gong
Lu Zhao
Lu Zhao
Jie Liu
Jie Liu
Nan Wu
Nan Wu
Coordinated regulation of IGF1R by HIF1α and HIF2α enhances chemoresistance in glioblastoma
Frontiers in Pharmacology
glioblastoma multiforme
HIF1α
HIF2α
IGF1R
hypoxic microenvironment
chemoresistance
title Coordinated regulation of IGF1R by HIF1α and HIF2α enhances chemoresistance in glioblastoma
title_full Coordinated regulation of IGF1R by HIF1α and HIF2α enhances chemoresistance in glioblastoma
title_fullStr Coordinated regulation of IGF1R by HIF1α and HIF2α enhances chemoresistance in glioblastoma
title_full_unstemmed Coordinated regulation of IGF1R by HIF1α and HIF2α enhances chemoresistance in glioblastoma
title_short Coordinated regulation of IGF1R by HIF1α and HIF2α enhances chemoresistance in glioblastoma
title_sort coordinated regulation of igf1r by hif1α and hif2α enhances chemoresistance in glioblastoma
topic glioblastoma multiforme
HIF1α
HIF2α
IGF1R
hypoxic microenvironment
chemoresistance
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1575332/full
work_keys_str_mv AT binliao coordinatedregulationofigf1rbyhif1aandhif2aenhanceschemoresistanceinglioblastoma
AT binliao coordinatedregulationofigf1rbyhif1aandhif2aenhanceschemoresistanceinglioblastoma
AT panwang coordinatedregulationofigf1rbyhif1aandhif2aenhanceschemoresistanceinglioblastoma
AT shenggong coordinatedregulationofigf1rbyhif1aandhif2aenhanceschemoresistanceinglioblastoma
AT luzhao coordinatedregulationofigf1rbyhif1aandhif2aenhanceschemoresistanceinglioblastoma
AT luzhao coordinatedregulationofigf1rbyhif1aandhif2aenhanceschemoresistanceinglioblastoma
AT jieliu coordinatedregulationofigf1rbyhif1aandhif2aenhanceschemoresistanceinglioblastoma
AT jieliu coordinatedregulationofigf1rbyhif1aandhif2aenhanceschemoresistanceinglioblastoma
AT nanwu coordinatedregulationofigf1rbyhif1aandhif2aenhanceschemoresistanceinglioblastoma
AT nanwu coordinatedregulationofigf1rbyhif1aandhif2aenhanceschemoresistanceinglioblastoma